COVID-19 Response ECHO for Oregon Clinicians

First and Third Thursdays of each month


This 12-Session program will support clinicians, staff and other healthcare professionals during the COVID-19 pandemic. Jointly presented with the Oregon Health Authority, sessions will look at Oregon's response to the pandemic, the state of the science in treatment and prevention, and offer guidance to practices for systems change. 

  • Learn strategies to optimize the treatment and prevention of COVID-19 while keeping staff and others safe
  • Stay current on the Oregon Health Authority’s latest guidance for Oregon healthcare practices
  • Receive guidance on evidence-based treatments for COVID-19
  • Share and receive advice on systems change within practices. 

CME Information

To earn CME or MOC Part II credits, you must fill out the Survey sent to you at the end of each session.

**Accreditation: Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

OHSU School of Medicine designates this live activity for a maximum of 12.0 AMA PRA Category 1 CreditsTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity.


Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, the COVID-19 Response ECHO for Oregon Clinicians has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

  • Allergy and Immunology
  • Preventive Medicine
  • Psychiatry and Neurology


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program forInfectious Disease and Internal Medicine. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Member boards require an assessment in order to award MOC Part 2 points.

You will be asked to provide a short (25 word minimum) reflection for each session you attended. The reflection should take the form of a clinical pearl from the talk that you will take back to your practice or share with a colleague. This reflection is separate from the speaker evaluation and should refer to your learning, rather than the content or quality of the talk. The reflections will be anonymized and shared with other participants and with the speakers.

  • MOC points equivalent to the CME credit available for that talk can be earned for each reflection you complete.
  • Reflections are only required for talks for which you wish to earn MOC points.
  • Reflections are not required in order to receive CME credit.

CME certificates will be emailed to you 6-8 weeks after the end of the sessions. For ABIM-certified physicians (Internal and Infectious Disease), OHSU will report your participation. For ABMS certified physicians, you will use your OHSU CME credit certificates to report your own participation. 

In accordance with the requirements of the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education, each instructor and member of the planning committee has been asked to disclose any relevant financial relationships with commercial interests (defined as: any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). The information disclosed for this activity is listed below.




Tanya Kapka, MD, MPH Nothing to Disclose
Ronald Stock, MD, MANothing to Disclose




Shelby Lee Freed, FNP Nothing to Disclose
Thomas Jeanne, MD, MPHNothing to Disclose
Tanya Kapka, MD, MPH Nothing to Disclose
Mark Slifka, MD Nothing to Disclose
Ronald Stock, MDNothing to Disclose
Holly Tse, MD Nothing to Disclose
Eric Wiser, MD 
Name of commercial interest Who has the relationship? What is the relationship? What was received?
3M myself Stockholder We own shares of 3M that are in an IRA. No benefits were received

Jay Richards, DO  
Name of commercial interest Who has the relationship? What is the relationship? What was received?  
Simple Screens, Inc myself Founder Stock Simple Screens is a start up organization working to implement medical screenings into clinics.
Neuropathic Pain Specialists myself Founder Salary Start up organization using Scrambler Therapy to treat neuropathic pain. 


Session/Title Date
1 - Vaccination Issues 1/7/2021
2 - Vaccination Rollout (cont.) 1/21/2021
3 - Vaccines 2/4/2021
4 - COVID-19 Variants 2/18/2021
5 - Long-Haulers 3/4/2021
6 - Testing 3/18/2021
7 - Oregon Immunization Program 4/1/2021
8 - Pediatric COVID 4/15/2021
9 - Vaccine Outreach to High Risk Populations 5/6/2021
10 - Session 10 5/20/2021
11 - Session 11 6/3/2021
12 - Session 12 6/17/2021
Sign Up For This ECHO